Related Experiment Video
Updated: Dec 1, 2025
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Evaluating the role of methicillin-resistant Staphylococcus aureus (MRSA)-specific antibiotic prophylaxis for
Arjun Rohit Adapa1, Joseph Raynor Linzey2, Badih Junior Daou2
1University of Michigan Medical School, Ann Arbor, MI, USA; Department of Neurosurgery, University of Michigan, Ann Arbor, MI, USA.
Objective:
Surgical site infection (SSI) in neurosurgical patients increases morbidity. Despite the rise of methicillin-resistant Staphylococcus aureus (MRSA) colonization, there is little consensus regarding antibiotic prophylaxis for SSI in MRSA-colonized neurosurgical patients. Our objective was to examine the incidence of SSI in MRSA-colonized neurosurgical patients and interrogate whether MRSA-specific antibiotic prophylaxis reduces SSIs.
Methods:
We performed a retrospective analysis of adult patients undergoing neurosurgical procedures between 2013 and 2018. The primary outcome was SSI in patients with MRSA colonization receiving MRSA-specific antibiotics. Secondary outcomes included predictors of SSI, including whether broad use of MRSA-specific antibiotics affects SSI rate.
Results:
Of 9739 procedures, 376 had SSI (3.9 %). Seven hundred forty-four procedures (7.6 %) were performed on patients screened preoperatively for MRSA, including 54 procedures on MRSA-colonized patients. MRSA-colonized patients were more likely than MRSA-non-colonized patients to receive MRSA-specific antibiotics (35.2 % vs. 17.8 %, p = 0.002) for prophylaxis. Nevertheless, MRSA-colonized patients had higher SSI rates compared to MRSA-non-colonized patients (22.2 % vs. 6.4 %, p = 0.00002). MRSA-colonization led to 3.49 greater odds (95 % CI 1.52-7.65, p = 0.002) of SSI relative to MRSA-non-colonization. MRSA-colonized patients receiving MRSA-specific antibiotics, compared to those receiving non-MRSA-specific antibiotics, had lower SSI rates, but this difference was not statistically significant (15.8 % vs. 25.7 %, p = 0.40). In the non-screened population, those receiving MRSA-specific antibiotics, compared to those receiving non-MRSA-specific antibiotics, had significantly higher SSI rates (6.9 % vs. 3.0 %, p = 0.00001). The use of MRSA-specific antibiotic prophylaxis in the non-screened population increased the odds of SSI (OR 1.90, 95 % CI 1.45-2.46, p = 0.0001).
Conclusion:
MRSA-colonized neurosurgical patients had a higher SSI rate compared to MRSA-non-colonized patients. While MRSA-specific antibiotics may benefit those with MRSA colonization, the difference in SSI rate between MRSA-colonized patients receiving MRSA-specific antibiotics vs. non-specific antibiotics requires further investigation. The broader use of MRSA-specific antibiotics may paradoxically confer an increased risk of SSI in a non-screened neurosurgical population.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) colonization increases surgical site infection (SSI) risk in neurosurgery patients. MRSA-specific antibiotics may offer benefits, but broader use in non-screened patients paradoxically raises SSI rates.
Area of Science:
- Neurosurgery
- Infectious Disease
- Clinical Pharmacy
Background:
- Surgical site infections (SSIs) are a significant complication in neurosurgical procedures.
- The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) colonization poses challenges for effective antibiotic prophylaxis.
- There is a lack of consensus on optimal SSI prevention strategies for MRSA-colonized neurosurgical patients.
Purpose of the Study:
- To investigate the incidence of SSIs in neurosurgical patients colonized with MRSA.
- To determine if MRSA-specific antibiotic prophylaxis reduces SSI rates in this population.
- To identify predictors of SSI, including the impact of broad MRSA-specific antibiotic use.
Main Methods:
- Retrospective analysis of adult neurosurgical patients from 2013-2018.
- Primary outcome: SSI in MRSA-colonized patients receiving MRSA-specific antibiotics.
- Secondary outcomes: SSI predictors and effect of broad MRSA-specific antibiotic use on SSI rates.
Main Results:
- MRSA-colonized patients had significantly higher SSI rates (22.2%) compared to non-colonized patients (6.4%).
- MRSA colonization increased the odds of SSI by 3.49.
- In non-screened patients, MRSA-specific antibiotic use was associated with significantly higher SSI rates (6.9% vs. 3.0%).
Conclusions:
- MRSA-colonized neurosurgical patients face a higher risk of SSIs.
- The benefit of MRSA-specific antibiotics in colonized patients warrants further investigation.
- Widespread use of MRSA-specific antibiotics in non-screened neurosurgical populations may paradoxically increase SSI risk.
Related Concept Videos
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:22Aneurysm IV: Nursing Management
01:30Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
01:26Mitral Stenosis III: Medical Management